article thumbnail

What's Market: Alternative Dispute Resolution Provisions

JD Supra: Mergers

arbitration or mediation). In M&A purchase agreements, the parties may stipulate certain non-judicial means for dealing with claims under the agreement (e.g., These ADR provisions will govern how disputes between the parties are to be handled. Originally Published in Bloomberg Law. By: Goulston & Storrs PC

Mediation 171
article thumbnail

Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

Global Newswire by Notified: M&A

Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Company Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biogen Completes Acquisition of Human Immunology Biosciences

Global Newswire by Notified: M&A

(Nasdaq: BIIB) has completed the acquisition of Human Immunology Biosciences (HI-Bioâ„¢), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases (IMDs).

article thumbnail

EIB Working Paper 2024/05 - A positive trade-off: Emissions reduction and costs under Phase IV of the Emissions Trading System

European Investment Bank

The results identify investment as a key channel, which mediates the effect of ETS prices on the carbon efficiency of firms.

article thumbnail

Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences

Global Newswire by Notified: M&A

(Nasdaq: BIIB) and Human Immunology Biosciences (HI-Bioâ„¢), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire HI-Bio for $1.15

article thumbnail

Leadership Development: A Critical Factor in M&A Success

Sun Acquisitions

Resolve Conflicts: They can mediate disputes and build consensus among different stakeholders. Effective leaders can: Drive the Integration Process: They can set the vision, communicate effectively, and motivate employees to achieve common goals. Manage Change: They can help employees adapt to change and minimize disruption.

M&A 58
article thumbnail

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

Global Newswire by Notified: M&A

Transaction to add clinical-stage program directed towards treating unmet needs in autoantibody-mediated diseases Combined company expected to have.